Hypothalamic AMP-activated protein kinase mediates counter-regulatory responses to hypoglycaemia in rats

被引:119
|
作者
Han, SM
Namkoong, C
Jang, PG
Park, IS
Hong, SW
Katakami, H
Chun, S
Kim, SW
Park, JY
Lee, KU
Kim, MS [1 ]
机构
[1] Univ Ulsan, Coll Med, Dept Internal Med, Seoul 138736, South Korea
[2] Univ Ulsan, Coll Med, Asan Inst Life Sci, Seoul, South Korea
[3] Inha Univ, Coll Med, Dept Anat, Inchon, South Korea
[4] Miyazaki Med Coll, Dept Internal Med, Miyazaki 88916, Japan
[5] Univ Ulsan, Coll Med, Dept Lab Pathol, Seoul, South Korea
关键词
AMP-activated protein kinase; catecholamines; corticosterone; counter-regulatory response; glucagon; hypoglycaemia; hypothalamus; neuroendocrine; paraventricular nucleus; ventromedial hypothalamus;
D O I
10.1007/s00125-005-1913-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/hypothesis: Appropriate counter-regulatory hormonal responses are essential for recovery from hypoglycaemia. Although the hypothalamus is known to be involved in these responses, the molecular mechanisms have not been fully elucidated. AMP-activated protein kinase (AMPK) functions as a cellular energy sensor, being activated during energy depletion. As AMPK is expressed in the hypothalamus, an important site of neuroendocrine regulation, the present study was undertaken to determine whether hypothalamic AMPK mediates counter-regulatory responses to hypoglycaemia. Materials and methods: Hypoglycaemia was induced by i.p. injection of regular insulin (6 U/kg) in Sprague-Dawley rats. Hypothalamic AMPK phosphorylation and activities were determined 1 h after i.p. insulin injection. To investigate the role of hypothalamic AMPK activation in mediating counter-regulatory responses, an AMPK inhibitor, compound C, was pre-administered intracerebroventricularly (i.c.v.) or dominant-negative (DN)-AMPK was overexpressed in the hypothalamus before induction of hypoglycaemia. Results: Insulin-induced hypoglycaemia increased hypothalamic AMPK phosphorylation and alpha 2-AMPK activities in rats. The change was significant in the arcuate nucleus/ventromedial hypothalamus (ARC/VMH) and paraventricular nuclei (PVN). Prior i.c.v. administration of compound C attenuated hypoglycaemia-induced increases in plasma concentrations of corticosterone, glucagon and catecholamines, resulting in severe and prolonged hypoglycaemia. ARC/VMH DN-AMPK overexpression impaired early counter-regulation, as evidenced by reduced glucagon and catecholamine responses. In contrast, PVN DN-AMPK overexpression attenuated late counter-regulation and corticosterone responses. Conclusions/interpretation: Systemic hypoglycaemia causes hypothalamic AMPK activation, which is important for counter-regulatory hormonal responses. Our data indicate that hypothalamic AMPK acts as a fuel gauge, sensing the whole-body energy state and regulating not only energy homeostasis but also neuroendocrine functions.
引用
收藏
页码:2170 / 2178
页数:9
相关论文
共 50 条
  • [31] Exposure of Astrocytes to Hypoglycaemia and Pharmacological AMP-activated Protein Kinase Activators Alters Gliotransmission
    Walker, Julia Vlachaki
    Ashford, Michael
    Mccrimmon, Rory J.
    Beall, Craig
    DIABETES, 2015, 64 : A105 - A105
  • [32] The influence of thyroid state on hypothalamic AMP-activated protein kinase pathways in broilers
    Lamberigts, C.
    Wang, Y.
    Dierckx, T.
    Buys, N.
    Everaert, N.
    Buyse, J.
    GENERAL AND COMPARATIVE ENDOCRINOLOGY, 2021, 311
  • [33] Modulation of astrocytic lactate release during hypoglycaemia by AMP-activated protein kinase and noradrenaline
    Walker, J. M. Vlachaki
    Gabriel, J.
    Ashford, M. L. J.
    McCrimmon, R. J.
    Beall, C.
    DIABETIC MEDICINE, 2015, 32 : 62 - 63
  • [34] Binding of Cordycepin Monophosphate to AMP-Activated Protein Kinase and its Effect on AMP-Activated Protein Kinase Activation
    Wang, Zhanli
    Wang, Xing
    Qu, Kai
    Zhu, Ping
    Guo, Na
    Zhang, Ruiping
    Abliz, Zeper
    Yu, Hui
    Zhu, Haibo
    CHEMICAL BIOLOGY & DRUG DESIGN, 2010, 76 (04) : 340 - 344
  • [35] AMP-Activated Protein Kinase Mediates Cardioprotection in the Regenerative MRL Mouse Strain
    Varghese, Susan T.
    Holley-Cuthrell, Jenan
    Warren, Chad M.
    Kuenster, Ann
    Heydemann, Ahlke
    CIRCULATION RESEARCH, 2012, 111 (04)
  • [36] AMP-Activated Protein Kinase Mediates the Antiplatelet Effects of the Thiazolidinediones Rosiglitazone and Pioglitazone
    Liu, Yingqiu
    Park, Jung-Min
    Chang, Kyung-Hwa
    Huh, Hee Jin
    Lee, Kyeong
    Lee, Moo-Yeol
    MOLECULAR PHARMACOLOGY, 2016, 89 (02) : 313 - 321
  • [37] AMP-activated protein kinase mediates mitochondrial fission in response to energy stress
    Toyama, Erin Quan
    Herzig, Sebastien
    Courchet, Julien
    Lewis, Tommy L., Jr.
    Loson, Oliver C.
    Hellberg, Kristina
    Young, Nathan P.
    Chen, Hsiuchen
    Polleux, Franck
    Chan, David C.
    Shaw, Reuben J.
    SCIENCE, 2016, 351 (6270) : 275 - 281
  • [38] AMP-activated Protein Kinase Mediates Pressure Overload-induced Hypertrophy
    Wang, Jinli
    Quan, Nanhu
    Wang, Lin
    Cates, Courtney
    Li, Ji
    HYPERTENSION, 2016, 68
  • [39] AMP-activated protein kinase mediates VEGF-stimulated endothelial NO production
    Reihill, James A.
    Ewart, Marie-Ann
    Hardie, D. Grahame
    Salt, Ian P.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 354 (04) : 1084 - 1088
  • [40] Activating AMP-activated protein kinase without AMP
    Birnbaum, MJ
    MOLECULAR CELL, 2005, 19 (03) : 289 - 290